Selected original psychedelic research published by Fluence Lead Trainers.
By Elizabeth Nielson, PhD
Passie T, Loizaga-Velder A, Danforth A, et al. A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy. Journal of Psychopharmacology. 2025;0(0). doi:10.1177/02698811241282759
A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy
Journal of Psychopharmacology, 0, 0.
Gorman, I., Nielson, E.M., Molinar, A., Cassidy, K., & Sabbagh, J. (2021)
Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
Front. Psychol. 12:645246. doi: 10.3389/fpsyg.2021.645246
Tai, S. J.,Nielson, E. M., Lennard-Jones, M., Johanna Ajantaival, R. L., Winzer, R.,Richards, W. A., … & Malievskaia, E. (2021).
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.
Frontiers in Psychiatry, 12, 27.
Nielson, E. M., & Guss, J. (2018).
The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training.
Journal of Psychedelic Studies, 2(2), 64-73.
Nielson, E. M., May, D. G., Forcehimes, A. A.,& Bogenschutz, M. P. (2018).
The psychedelic debriefing in alcohol dependence treatment: Illustrating key change phenomena through qualitative content analysis of clinical sessions.
Frontiers in Pharmacology, 9, 132.
Nielson, E. M.
Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current Practice.
Journal of Humanistic Psychology. June 2021. doi:10.1177/00221678211021204
Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., . . . Malievskaia, E. (2022).
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
New England Journal of Medicine, 387(18), 1637-1648.
Agin-Liebes, G., Nielson, E. M., Zingman, M., Kim, K., Haas, A., Owens, L. T., Rogers, U., & Bogenschutz, M. (2023, June 5).
Reports of Self-Compassion and Affect Regulation in Psilocybin-Assisted Therapy for Alcohol Use Disorder: An Interpretive Phenomenological Analysis.
Psychology of Addictive Behaviors. Advance online publication. https://dx.doi.org/10.1037/adb0000935
McGuire AL, Cohen IG, Sisti D, et al.
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement.
JAMA Netw Open. 2024;7(6):e2414650. doi:10.1001/jamanetworkopen.2024.14650
By Ingmar Gorman, PhD
By Jeffrey Guss, MD
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone,T., Cohen, B., … & Schmidt, B. L. (2016).
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Journal of Psychopharmacology, 30(12), 1165-1180.
Swift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N.,Terrana, S., Friedman, H. L., … & Ross, S. (2017).
Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress.
Journal of Humanistic Psychology, 57(5), 488-519.
Nielson, E. M., & Guss, J. (2018).
The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training.
Journal of Psychedelic Studies,2(2), 64-73.
Malone, T. C., Mennenga, S. E., Guss, J., Podrebarac, S.K., Owens, L. T., Bossis, A. P., … & Ross, S. (2018).
Individual experiences in four cancer patients following psilocybin-assisted psychotherapy.
Frontiers in Pharmacology, 9, 256.
Sloshower, J., Guss, J., Krause, R., Wallace, R. M.,Williams, M. T., Reed, S., & Skinta, M. D. (2020).
Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame.
Journal of Contextual Behavioral Science, 15, 12-19.
Agin-Liebes, G. I., Malone, T.,Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., … & Ross, S.(2020).
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.
Journal of Psychopharmacology, 34(2), 155-166.
By Kelan Thomas, PharmD
Nguyen, L., Thomas, K. L., Lucke-Wold, B. P., Cavendish, J.Z., Crowe, M. S., & Matsumoto, R. R. (2016).
Dextromethorphan: An update onits utility for neurological and neuropsychiatric disorders.
Pharmacology & Therapeutics, 159, 1-22.
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C.,Abbas, A. I., Hufeisen, S. J., … & Roth, B. L. (2009).
Predicting new molecular targets for known drugs.
Nature, 462(7270), 175-181.
Thomas, K., Malcolm, B., & Lastra, D. (2017).
Psilocybin-assisted therapy: A review of a novel treatment for psychiatric disorders.
Journal of Psychoactive Drugs, 49(5), 446-455.
Thomas, K., & Malcolm, B.(2021). Adverse Effects.
Handbook of Medical Hallucinogens,
414.
By Casey Paleos, MD
By Dan Roberts, MD, MSW
Carrithers, B. M., Roberts, D. E., Weiss, B. M., King, J. D., Carhart-Harris, R. L., Gordon, A. R., Pagni, B. A., Moreau, M., Ross, S., & Zeifman, R. J. (2025).
Exploring serotonergic psychedelics as a treatment for personality disorders.
Neuropharmacology, 110413. https://doi.org/10.1016/j.neuropharm.2025.110413
Perron, Brian & Glass, Joseph & Ahmedani, Brian & Vaughn, Michael & Roberts, Daniel & Wu, Li-Tzy. (2011).
The prevalence and clinical significance of inhalant withdrawal symptoms among a national sample.
Substance abuse and rehabilitation. 2011. 69-76. 10.2147/SAR.S14937.
VanBronkhorst, Sara & Edwards, Evonne & Roberts, Daniel & Kist, Katie & Evans, Darci & Mahdasian, Alexandra & Blankenship, Kelly. (2017).
4.21 Depression, Suicidality, Substance Use, and Abuse History Among Lesbian, Gay, Bisexual, Transgender, Queer (LGBTQ) Adolescents Who Are Psychiatrically Hospitalized.
Journal of the American Academy of Child & Adolescent Psychiatry. 56. S235. 10.1016/j.jaac.2017.09.237.
Mathai, David & Roberts, Daniel & Nayak, Sandeep & Sepeda, Nathan & Lehrner, Amy & Johnson, Matthew & Lowe, Matthew & Jackson, Heather & Garcia-Romeu, Albert. (2023).
Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use.
10.31234/osf.io/hm6jn.
Vanbronkhorst, Sara B; Roberts, Daniel E; Edwards, Evonne M; Blankenship, Kelly.
Diagnosis and Use of Psychotherapy Among Children and Adolescents Prescribed Antipsychotics.
Journal of psychiatric practice. 2018:24(5):323-330.
Roberts, Daniel; Farahmand, Pantea; Wolkin, Adam.
Nitrous Oxide Inhalant Use Disorder Preceding Symptoms Concerning for Primary Psychotic Illness.
American journal on addictions. 2020:29(6):525-527.
Benville, Julia; Agin-Liebes, Gabrielle; Roberts, Daniel E.; Lo, Sharon; Ghazal, Leila; Franco-Corso, Silvia J.; Ross, Stephen.
Effects of Psilocybin on Suicidal Ideation in Patients With Life-Threatening Cancer.
Biological psychiatry. 2021:89(9):S235-S236.
Roberts, Daniel; Farahmand, Pantea; Wolkin, Adam.
Nitrous Oxide Inhalant Use Disorder Preceding Symptoms Concerning for Primary Psychotic Illness.
American journal on addictions. 2021:30(3):268-268.
Roberts, Daniel; Farahmand, Pantea; Wolkin, Adam.
Psychiatric consequences of nitrous oxide abuse.
Current psychiatry. 2021:20(2):E1-E2.
VanBronkhorst, Sara B; Edwards, Evonne M; Roberts, Daniel E; Kist, Katie; Evans, Darci L; Mohatt, Justin; Blankenship, Kelly.
Suicidality Among Psychiatrically Hospitalized Lesbian, Gay, Bisexual, Transgender, Queer, and/or Questioning Youth: Risk and Protective Factors.
LGBT health. 2021:8(6):395-403.
Kim, Katherine; Roberts, Daniel.
Hallucinogen-related disorders.
Addiction medicine: A case and evidence-based guide by Avery, Jonathan D [Ed]; Hankins, David [Ed]. Cham, Switzerland: Springer Nature Switzerland AG; Switzerland, 2022. ISBN: 978-3-030-86429-3.
Traynor, Jenna M; Roberts, Daniel E; Ross, Stephen; Zeifman, Richard; Choi-Kain, Lois.
MDMA-Assisted Psychotherapy for Borderline Personality Disorder.
Focus : the journal of lifelong learning in psychiatry. 2022:20(4):358-367.
O’Donnell, Kelley C.; Roberts, Daniel E; Ching, Terence H.W.; Glick, Gianni; Goldway, Noam; Gukasyan, Natalie; Hokansen, Jamila; Kelmendi, Benjamin; Ross, Stephen; Yaden, Mary E.; Pittenger, Christopher.
Letter to the Editor: What Is in a Name? The Many Meanings of Psychedelic.
Psychedelic medicine (New Rochelle, N.Y.). 2023.
Zeifman, Richard J; Kettner, Hannes; Pagni, Broc A; Mallard, Austin; Roberts, Daniel E; Erritzoe, David; Ross, Stephen; Carhart-Harris, Robin L.
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.
Scientific reports. 2023:13(1).
By Xiaojue Hu, MD
Raison CL, Sanacora G, Woolley J, et al.
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
JAMA. 2023;330(9):843–853.
Hu, X. Review of books
Third Culture Kids: Growing Up Among Worlds by D. Pollack & R. E. Van Reken, Raising Global Nomads by R. Pascoe, and The Global Nomad’s Guide to University Transition by T. L. Quick.
Group 2015; Vol. 39 (2): 173-176.
